Clinical Trial: YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment

U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07409805) titled 'YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment' on Jan. 14.

Brief Summary: This study aims to determine the safety and maximum tolerated dose (MTD) of YMN-136 vaccine through a dose escalation trial, and to investigate whether YMN-136 vaccine can assist in the treatment of patients with metastatic colorectal cancer.

Study Start Date: March 01

Study Type: INTERVENTIONAL

Condition: Colorectal Cancer

Intervention: BIOLOGICAL: YMN-136 Vaccine

The YMN-136 vaccine will be administered according to the dose level assigned to each patient. Approximately every 3 weeks, th...